KANT
Price
$0.21
Change
-$0.07 (-25.00%)
Updated
Apr 23 closing price
Capitalization
2.52M
NRSN
Price
$1.00
Change
+$0.01 (+1.01%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
23.46M
34 days until earnings call
Ad is loading...

KANT vs NRSN

Header iconKANT vs NRSN Comparison
Open Charts KANT vs NRSNBanner chart's image
Kineta
Price$0.21
Change-$0.07 (-25.00%)
Volume$70.16K
Capitalization2.52M
NeuroSense Therapeutics
Price$1.00
Change+$0.01 (+1.01%)
Volume$500
Capitalization23.46M
KANT vs NRSN Comparison Chart
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KANT vs. NRSN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KANT is a Hold and NRSN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (KANT: $0.21 vs. NRSN: $0.99)
Brand notoriety: KANT and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KANT: 468% vs. NRSN: 54%
Market capitalization -- KANT: $2.52M vs. NRSN: $23.46M
KANT [@Biotechnology] is valued at $2.52M. NRSN’s [@Biotechnology] market capitalization is $23.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KANT’s FA Score shows that 1 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • KANT’s FA Score: 1 green, 4 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, KANT is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 5 TA indicator(s) are bullish.

  • NRSN’s TA Score: 5 bullish, 5 bearish.

Price Growth

KANT (@Biotechnology) experienced а -25.16% price change this week, while NRSN (@Biotechnology) price change was -4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

NRSN is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($23.5M) has a higher market cap than KANT($2.52M). NRSN YTD gains are higher at: -17.754 vs. KANT (-41.225). NRSN has higher annual earnings (EBITDA): -10.41M vs. KANT (-20.45M). KANT has more cash in the bank: 900K vs. NRSN (344K). NRSN has less debt than KANT: NRSN (19K) vs KANT (710K). KANT (0) and NRSN (0) have equivalent revenues.
KANTNRSNKANT / NRSN
Capitalization2.52M23.5M11%
EBITDA-20.45M-10.41M196%
Gain YTD-41.225-17.754232%
P/E RatioN/AN/A-
Revenue00-
Total Cash900K344K262%
Total Debt710K19K3,737%
FUNDAMENTALS RATINGS
KANT: Fundamental Ratings
KANT
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRSN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSEM35.850.46
+1.30%
Tower Semiconductor Ltd
GRC33.340.36
+1.09%
Gorman-Rupp Company (The)
ANGO9.350.05
+0.54%
AngioDynamics
TPCS2.31N/A
N/A
TechPrecision Corp
CHT39.28-0.66
-1.65%
CHUNGHWA TELECOM CO Ltd

KANT and

Correlation & Price change

A.I.dvisor indicates that over the last year, KANT has been loosely correlated with MDGL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KANT jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KANT
1D Price
Change %
KANT100%
-27.79%
MDGL - KANT
62%
Loosely correlated
+2.01%
SLNO - KANT
45%
Loosely correlated
+1.22%
VKTX - KANT
35%
Loosely correlated
+1.22%
CELC - KANT
34%
Loosely correlated
-0.63%
MDWD - KANT
29%
Poorly correlated
N/A
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
-2.28%
SLRX - NRSN
32%
Poorly correlated
+9.26%
CTMX - NRSN
31%
Poorly correlated
-0.65%
DNLI - NRSN
29%
Poorly correlated
+1.85%
VKTX - NRSN
27%
Poorly correlated
+1.22%
KANT - NRSN
27%
Poorly correlated
-27.79%
More